| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 27.07. | Kimia Farma commissioner Sumarjati Arjoso passed away: Sumarjati Arjoso was appointed as a commissioner of Kimia ... | 1 | IDNFinancials | ||
| KIMIA FARMA Aktie jetzt für 0€ handeln | |||||
| 30.06. | Kimia Farma clarifies regarding 2026 international arbitration dispute: KAEF provided clarification regarding ... | 1 | IDNFinancials |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NOVO NORDISK | 34,485 | +0,13 % | Novo Nordisk-Aktie: Value-Falle oder Turnaround-Chance? | Für die Novo Nordisk-Aktie sah es zuletzt wieder deutlich freundlicher aus. Zwar kam es im September noch einmal zu einem kräftigen Rücksetzer, doch seit Anfang Oktober bestimmen die Bullen wieder das... ► Artikel lesen | |
| AURORA CANNABIS | 3,768 | -0,69 % | Das zwingt Anleger zum Handeln: Cannabisaktien am Wendepunkt: Warum Canopy, Tilray & Co. jetzt im Fokus stehen | © Foto: adobe.stock.comDie Quartalsberichte der Cannabis-Unternehmen boten Licht und Schatten - oder sollte man besser Hoffnung und Resignation sagen? Die Unterschiede hätten nicht größer sein können.... ► Artikel lesen | |
| CANOPY GROWTH | 0,400 | +1,16 % | Why Is Canopy Growth Stock Falling Friday? | ||
| ASTRAZENECA | 159,00 | -0,03 % | Wichtige Zulassung: Neuer Hoffnungsträger: AstraZeneca punktet in Europa und den USA | © Foto: Marcus Brandt - dpaGrünes Licht aus den USA und Europa: AstraZeneca darf ein neuartiges Medikament gegen eine seltene Autoimmunerkrankung auf den Markt bringen Enthaltene Werte: GB0009895292Den... ► Artikel lesen | |
| TILRAY BRANDS | 1,710 | -0,58 % | Is Tilray a Buy at Its Record Low, or Is It a Value Trap? | ||
| VERTEX PHARMACEUTICALS | 468,75 | -0,26 % | Genomics Limited: Genomics Ltd. Announces Extension of Strategic Drug Discovery Collaboration with Vertex Pharmaceuticals | Genomics Ltd. Announces Extension of Strategic Drug Discovery Collaboration with Vertex Pharmaceuticals
The new agreement extends an existing 8-year collaboration between the companies OXFORD,... ► Artikel lesen | |
| TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -2- | The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameCA83013Q8719 CORE... ► Artikel lesen | |
| CRONOS GROUP | 2,790 | +0,14 % | Cronos Group Inc.: Cronos Group Reports 2026 Second Quarter Results | Organically achieved record net revenue, gross profit, and Adjusted EBITDA while reducing share count Net revenue in Q2 2026 increased by 51% year-over-year on an organic, constant-currency basis... ► Artikel lesen | |
| DIGICANN VENTURES | 0,006 | 0,00 % | CSE Bulletin: Halted for Fundamental Change - Digicann Ventures Inc. (DCNN.X) | Le 6 novembre/November 2026
Trading in the shares of Digicann Ventures Inc. will remain halted pending receipt and review of acceptable documentation regarding the Fundamental Change pursuant to... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 0,566 | +3,10 % | Organigram Global Inc: Organigram has 180 days to cure Nasdaq non-compliance | ||
| GREEN THUMB INDUSTRIES | 5,150 | +2,59 % | Green Thumb Has $316 Million in Cash, and Same-Store Sales Are Growing Again. Is It the Smartest Pot Stock to Buy? | ||
| NOVERIS HEALTH SCIENCES | 0,002 | -92,50 % | Noveris Health Sciences Inc.: Noveris Health Sciences Announces Commencement of Strategic Review Process | Vancouver, British Columbia--(Newsfile Corp. - November 13, 2026) - Noveris Health Sciences Inc. (CSE: NVRS) (FSE: 0NF1) (OTC Pink: MYCOF) (the "Company" or "Noveris") announces that its board of directors... ► Artikel lesen | |
| CSPC PHARMA | 0,888 | 0,00 % | CICC: CSPC PHARMA 3Q Results in line, Core Business Remains Solid | ||
| SANTHERA PHARMACEUTICALS | 13,920 | +1,90 % | Santhera Pharmaceuticals Holding AG: Santhera Signs Distribution Agreement with SteinCares for AGAMREE (Vamorolone) in 31 countries across Latin America and the Caribbean | Pratteln, Switzerland, November 12, 2026 - Santhera Pharmaceuticals (SIX: SANN) announces it has signed an exclusive agreement with SteinCares for the distribution of AGAMREE (vamorolone) for the treatment... ► Artikel lesen | |
| NEKTAR THERAPEUTICS | 28,070 | +1,78 % | Nektar Therapeutics: New Rezpegaldesleukin Data Supporting Long-term Durability and Disease Improvement in Patients with Alopecia Areata and Atopic Dermatitis at EADV Congress 2026 | Rezpegaldesleukindemonstrateddurabilityanddeepeningofresponsethroughone year of treatment in two dermatological indications, reinforcing the differentiated properties... ► Artikel lesen |